2024 |
Y-Mabs Therapeutics Inc
|
Vice Chairman of the Board and Chief Business Officer |
2.1 M |
- |
2023 |
Y-Mabs Therapeutics Inc
|
Vice Chairman of the Board and Chief Business Officer |
2.5 M |
71.0 % |
2023 |
Y-Mabs Therapeutics Inc
|
Vice Chairman of the Board and Chief Business Officer |
- |
- |
2022 |
Y-Mabs Therapeutics Inc
|
President, Interim Chief Executive Officer, Head of Business Development & Strategy and Director |
1.4 M |
-23.1 % |
2021 |
Y-Mabs Therapeutics Inc
|
- |
1.9 M |
-49.2 % |
2021 |
Y-Mabs Therapeutics Inc
|
President, Interim Chief Executive Officer, Head of Business Development and Strategy and Director |
1.9 M |
-49.2 % |
2020 |
Y-Mabs Therapeutics Inc
|
- |
3.7 M |
379.7 % |
2020 |
Y-Mabs Therapeutics Inc
|
Chairman of the Board, President and Head of Business Development and Strategy |
3.7 M |
379.7 % |
2020 |
Y-Mabs Therapeutics Inc
|
- |
3.7 M |
379.7 % |
2019 |
Y-Mabs Therapeutics Inc
|
- |
3.1 M |
15.3 % |
2019 |
Y-Mabs Therapeutics Inc
|
- |
3.1 M |
15.3 % |
2019 |
Y-Mabs Therapeutics Inc
|
Chairman of the Board, President and Head of Business Development and Strategy |
766.7 K |
-71.1 % |
2018 |
Y-Mabs Therapeutics Inc
|
- |
2.7 M |
344.4 % |
2018 |
Y-Mabs Therapeutics Inc
|
Chairman of the Board, President and Head of Business Development |
2.7 M |
344.4 % |
2018 |
Y-Mabs Therapeutics Inc
|
- |
2.7 M |
344.4 % |
2017 |
Y-Mabs Therapeutics Inc
|
- |
597.6 K |
- |
2017 |
Y-Mabs Therapeutics Inc
|
- |
597.6 K |
- |
2017 |
Y-Mabs Therapeutics Inc
|
Chairman of the Board of Directors, President and Head of Business Development |
597.6 K |
- |